BACKGROUND: Previous reports suggested that US methicillin-resistant Staphylococcus aureus (MRSA) strain epidemiology has changed since the rise of USA300 MRSA. We describe invasive MRSA trends by strain type. METHODS: Data came from 5 Centers for Disease Control and Prevention Emerging Infections Program sites conducting population-based surveillance and collecting isolates for invasive MRSA (ie, from normally sterile body sites), 2005-2013. MRSA bloodstream infection (BSI) incidence per 100 000 population was stratified by strain type and epidemiologic classification of healthcare exposures. Invasive USA100 vs USA300 case characteristics from 2013 were compared through logistic regression. RESULTS: From 2005 to 2013, USA100 incidence decreased most notably for hospital-onset (6.1 vs 0.9/100 000 persons, P < .0001) and healthcare-associated, community-onset (10.7 vs 4.9/100 000 persons, P < .0001) BSIs. USA300 incidence for hospital-onset BSIs also decreased (1.5 vs 0.6/100 000 persons, P < .0001). However, USA300 incidence did not significantly change for healthcare-associated, community-onset (3.9 vs 3.3/100 000 persons, P = .05) or community-associated BSIs (2.5 vs 2.4/100 000 persons, P = .19). Invasive MRSA was less likely to be USA300 in patients who were older (adjusted odds ratio [aOR], 0.97 per year [95% confidence interval {CI}, .96-.98]), previously hospitalized (aOR, 0.36 [95% CI, .24-.54]), or had central lines (aOR, 0.44 [95% CI, .27-.74]), and associated with USA300 in people who inject drugs (aOR, 4.58 [95% CI, 1.16-17.95]). CONCLUSIONS: Most of the decline in MRSA BSIs was from decreases in USA100 BSI incidence. Prevention of USA300 MRSA BSIs in the community will be needed to further reduce burden from MRSA BSIs. Published by Oxford University Press for the Infectious Diseases Society of America 2019.
BACKGROUND: Previous reports suggested that US methicillin-resistant Staphylococcus aureus (MRSA) strain epidemiology has changed since the rise of USA300 MRSA. We describe invasive MRSA trends by strain type. METHODS: Data came from 5 Centers for Disease Control and Prevention Emerging Infections Program sites conducting population-based surveillance and collecting isolates for invasive MRSA (ie, from normally sterile body sites), 2005-2013. MRSA bloodstream infection (BSI) incidence per 100 000 population was stratified by strain type and epidemiologic classification of healthcare exposures. Invasive USA100 vs USA300 case characteristics from 2013 were compared through logistic regression. RESULTS: From 2005 to 2013, USA100 incidence decreased most notably for hospital-onset (6.1 vs 0.9/100 000 persons, P < .0001) and healthcare-associated, community-onset (10.7 vs 4.9/100 000 persons, P < .0001) BSIs. USA300 incidence for hospital-onset BSIs also decreased (1.5 vs 0.6/100 000 persons, P < .0001). However, USA300 incidence did not significantly change for healthcare-associated, community-onset (3.9 vs 3.3/100 000 persons, P = .05) or community-associated BSIs (2.5 vs 2.4/100 000 persons, P = .19). Invasive MRSA was less likely to be USA300 in patients who were older (adjusted odds ratio [aOR], 0.97 per year [95% confidence interval {CI}, .96-.98]), previously hospitalized (aOR, 0.36 [95% CI, .24-.54]), or had central lines (aOR, 0.44 [95% CI, .27-.74]), and associated with USA300 in people who inject drugs (aOR, 4.58 [95% CI, 1.16-17.95]). CONCLUSIONS: Most of the decline in MRSA BSIs was from decreases in USA100 BSI incidence. Prevention of USA300 MRSA BSIs in the community will be needed to further reduce burden from MRSA BSIs. Published by Oxford University Press for the Infectious Diseases Society of America 2019.
Authors: Scott K Fridkin; Jeffrey C Hageman; Melissa Morrison; Laurie Thomson Sanza; Kathryn Como-Sabetti; John A Jernigan; Kathleen Harriman; Lee H Harrison; Ruth Lynfield; Monica M Farley Journal: N Engl J Med Date: 2005-04-07 Impact factor: 91.245
Authors: Matthew E Wise; R Douglas Scott; James M Baggs; Jonathan R Edwards; Katherine D Ellingson; Scott K Fridkin; L Clifford McDonald; John A Jernigan Journal: Infect Control Hosp Epidemiol Date: 2013-04-18 Impact factor: 3.254
Authors: Seema Jain; Wesley H Self; Richard G Wunderink; Sherene Fakhran; Robert Balk; Anna M Bramley; Carrie Reed; Carlos G Grijalva; Evan J Anderson; D Mark Courtney; James D Chappell; Chao Qi; Eric M Hart; Frank Carroll; Christopher Trabue; Helen K Donnelly; Derek J Williams; Yuwei Zhu; Sandra R Arnold; Krow Ampofo; Grant W Waterer; Min Levine; Stephen Lindstrom; Jonas M Winchell; Jacqueline M Katz; Dean Erdman; Eileen Schneider; Lauri A Hicks; Jonathan A McCullers; Andrew T Pavia; Kathryn M Edwards; Lyn Finelli Journal: N Engl J Med Date: 2015-07-14 Impact factor: 91.245
Authors: B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum Journal: JAMA Date: 1998-02-25 Impact factor: 56.272
Authors: Alexander J Kallen; Yi Mu; Sandra Bulens; Arthur Reingold; Susan Petit; Ken Gershman; Susan M Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; William Schaffner; Priti R Patel; Scott K Fridkin Journal: JAMA Date: 2010-08-11 Impact factor: 56.272
Authors: Brandi Limbago; Gregory E Fosheim; Valerie Schoonover; Christina E Crane; Joelle Nadle; Susan Petit; David Heltzel; Susan M Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; William Schaffner; Yi Mu; Scott K Fridkin Journal: J Clin Microbiol Date: 2009-03-25 Impact factor: 5.948
Authors: Linda K McDougal; Christine D Steward; George E Killgore; Jasmine M Chaitram; Sigrid K McAllister; Fred C Tenover Journal: J Clin Microbiol Date: 2003-11 Impact factor: 5.948
Authors: M B Frisch; S Castillo-Ramírez; R A Petit; M M Farley; S M Ray; V S Albrecht; B M Limbago; J Hernandez; I See; S W Satola; T D Read Journal: mSphere Date: 2018-05-02 Impact factor: 4.389
Authors: D Cal Ham; Isaac See; Shannon Novosad; Matthew Crist; Garrett Mahon; Lucy Fike; Kevin Spicer; Pamela Talley; Andrea Flinchum; Marion Kainer; Alexander J Kallen; Maroya Spalding Walters Journal: J Hosp Infect Date: 2020-04-10 Impact factor: 3.926
Authors: Makoto Jones; John A Jernigan; Martin E Evans; Gary A Roselle; Kelly M Hatfield; Matthew H Samore Journal: MMWR Morb Mortal Wkly Rep Date: 2019-03-08 Impact factor: 17.586
Authors: Robert J Miller; Heidi A Crosby; Katrin Schilcher; Yu Wang; Roger V Ortines; Momina Mazhar; Dustin A Dikeman; Bret L Pinsker; Isabelle D Brown; Daniel P Joyce; Jeffrey Zhang; Nathan K Archer; Haiyun Liu; Martin P Alphonse; Julie Czupryna; William R Anderson; Nicholas M Bernthal; Lea Fortuno-Miranda; Jeff W M Bulte; Kevin P Francis; Alexander R Horswill; Lloyd S Miller Journal: Sci Rep Date: 2019-11-13 Impact factor: 4.379
Authors: Lisanne de Vor; Bruce van Dijk; Kok van Kessel; Jeffrey S Kavanaugh; Carla de Haas; Piet C Aerts; Marco C Viveen; Edwin C Boel; Ad C Fluit; Jakub M Kwiecinski; Gerard C Krijger; Ruud M Ramakers; Freek J Beekman; Ekaterina Dadachova; Marnix Geh Lam; H Charles Vogely; Bart Ch van der Wal; Jos Ag van Strijp; Alexander R Horswill; Harrie Weinans; Suzan Hm Rooijakkers Journal: Elife Date: 2022-01-06 Impact factor: 8.140
Authors: Philip M Roper; Kara R Eichelberger; Linda Cox; Luke O'Connor; Christine Shao; Caleb A Ford; Stephanie A Fritz; James E Cassat; Deborah J Veis Journal: Infect Immun Date: 2021-06-07 Impact factor: 3.441